Stock·NASDAQ·Technology
Quantum Computing Inc. (QUBT)
- Market cap
- $1.44B
- Dividend yield
- 0.00%
- Street target
- $18.00median of 6 analysts
- 52-week range
- $6.08 $18.88
The short version
Where QUBT stands today, in four lines, and what CleaRank Financial AI makes of it.
QUBT at a glance
Quantum Computing Inc. (QUBT): Sell, 39/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($8.21 and $8.99).
- Earnings QUBT beat estimates in 5 of its last 7 quarters, and the stock rose the next day every time.
- Insiders Insiders sold $32.1M and made no open-market purchases over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Quantum Computing Inc. (QUBT) Sell, with a model score of 39/100.
The analysts' outlook lifts the score most: 4 of 6 analysts rate it a buy and the median target is 183.0% above the price. The trend holds it back most: the price is 29.28% below its 200-day average and 22.57% below its 50-day average, and the 50-day average is 8.66% below the 200-day. The 50-day average stands at $8.21 and the 200-day at $8.99. Over the past year the price fell 66.06%.
Only on CleaRank
Figures we compute ourselves from QUBT's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $6.36 is 22.6% below the 50-day simple moving average of $8.21.Price above its 200-day average ›
The price is 29.3% below the 200-day simple moving average of $8.99.50-day average above the 200-day ›
The 50-day average ($8.21) is 8.7% below the 200-day average ($8.99), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 2% of its 52-week range, between $6.08 and $18.88.
QUBT share price
Pick a period: each tab shows how far QUBT has moved over it, to the last close.
Today's trading
Where QUBT sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/S below the sector median ›
The price-to-sales ratio of 146.54 is 1,828.1% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $-15.0M on revenue of $9.8M, a net margin of -152.5%.Beat estimates in most recent reports ›
QUBT beat the EPS estimate in 5 of its last 7 reports.
Key statistics
The headline figures for QUBT.
As of October 17, 2026, QUBT trades at $6.36, with a market value of $1.44B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of QUBT's valuation, growth and risks.
Quantum Computing Inc. (QUBT) has no readable P/E, because the company lost money over the last 12 months, which makes the ratio not meaningful. Its price-to-sales ratio of 146.54 is 1,828.2% above the sector median of 7.6. To put the size in context, the market capitalisation is $1.4B, and trailing earnings are -$0.05 a share.
QUBT is losing money. Its net margin stands at -152.45% and its operating margin at -281.27%, while return on equity of -1.51% sits below the sector median of 13.4%. On growth, the company is ahead of its sector: revenue rose 9,000.00% in the latest year, compared with a sector median of 24.2%. Debt-to-equity of 0.01 completes the picture.
QUBT reported earnings on August 10, 2026, beating the estimate by 20.00%. The company posted EPS of -$0.04, while analysts had expected -$0.05. In the next session, the shares rose 0.22%.
Over its last 7 reports, QUBT topped the estimate 5 times, and every one of those beats was followed by a gain the next day. The May 11, 2026 report stands out among the earlier ones: a beat of 40.00%, after which the stock rose 15.72%. Looking ahead, analysts expect EPS of -$0.2333 this fiscal year and -$0.2367 the year after.
On a typical day the price of QUBT shifts by 3.50%, the 30-day standard deviation of its daily returns. Until the price regains its moving averages, the trend works against holders. The price is 66.31% below its 52-week high of $18.88. Insiders sold $32.1M over the last 18 months and bought none on the open market, though sales of this kind are often planned in advance and say less than purchases would.
QUBT against the Technology sector
How QUBT compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, QUBT trades at 146.54x, far above the sector average of 7.60x.
Return vs XLK: Since May 6, 2025, QUBT has lost 10.2% against a gain of 73.7% for XLK.
Performance against XLK
QUBT and the Technology sector fund over the same days.
Revenue and earnings
How much QUBT sells, and how much of it becomes profit.
Revenue growth: Revenue grew 82.8% in FY2025 to $682K, from $373K a year earlier.
Profit margin: The net margin was -2,738.1% in FY2025, up from -18,375.9% the year before.
Loss-making: QUBT lost $18.7M in FY2025.
Earnings reality check
Did QUBT beat what analysts expected, and how did the stock react?
Earnings record: QUBT beat the analyst estimate in 5 of the last 7 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 10, 2026after close | -$0.05 | -$0.04 | +20.00% | +0.22% | +1.34% |
| May 11, 2026after close | -$0.05 | -$0.03 | +40.00% | +15.72% | -4.57% |
| Nov 14, 2025after close | -$0.05 | $0.07 | +240.00% | +8.49% | -3.77% |
| Aug 14, 2025after close | -$0.06 | -$0.06 | +0.00% | -0.39% | -4.49% |
| May 15, 2025after close | -$0.07 | -$0.05 | +28.57% | +39.29% | +30.63% |
| Mar 20, 2025after close | -$0.05 | -$0.10 | -100.00% | +0.00% | +7.44% |
| Nov 6, 2024after close | -$0.08 | -$0.06 | +25.00% | +25.00% | +146.30% |
As of October 17, 2026, QUBT has beaten the analyst EPS estimate in 5 of its last 7 reported quarters and rose in the first trading session after every one of those beats; its latest report, on August 10, 2026, came in 20.00% above the estimate and the stock moved +0.22% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 29.2, in oversold territory.RSI above 50 ›
An RSI of 29.2 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of QUBT
The score, the reasoning behind it, and what could move the price next.
QUBT is trading in a downtrend. At $6.36, the stock sits 22.57% below its 50-day average of $8.21 and 29.28% below its 200-day average of $8.99. Near the bottom of its 52-week range, the price is 4.61% above the low of $6.08 and 66.31% below the high of $18.88. The 50-day average is 8.66% below the 200-day, a gap that backs up the weakness shown by the price.
The 14-day RSI of 29.2 is in oversold territory, and the MACD line is negative. The record is negative across every period shown: the price fell 18.46% over the past three months, fell 33.54% over the past six months and fell 66.06% over the past year.
Earnings beat ›
The August 10, 2026 report beat the EPS estimate by 20.00%, and the share price rose 0.22% in the first session after it.
Source: Earnings report, August 10, 2026
Rating reaffirmed ›
Ascendiant Capital kept its Buy rating on August 26, 2026.
Source: Analyst action, Ascendiant Capital, August 26, 2026
- The two closest levels matter most: the 20-day EMA at $7.56 sits above the price, and the 52-week low at $6.08 sits below it.
- A 14-day RSI of 29.2 places QUBT in the oversold zone, and the MACD line is negative. Readings above 70 or below 30 point to stretched momentum.
- Following the August 10, 2026 report, the share price rose 0.22% in the first session. Over the last 7 reports, QUBT beat estimates in 5.
The trend is down because QUBT trades under both its 50-day ($8.21) and 200-day ($8.99) averages. Reclaiming the 50-day would be the first sign of repair. Above the price, the first level to watch is the 20-day EMA, at $7.56.
The 52-week low at $6.08 is the next level below. Momentum is washed out, with the RSI below the oversold line; a turn back above it would be an early sign of stabilising.
Technical indicators
Momentum and trend for QUBT, from its daily closes.
As of October 17, 2026, with QUBT at $6.36, its 14-day RSI is 29.2 (oversold territory), its 50-day simple moving average is $8.21 and its 200-day is $8.99.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What QUBT moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, QUBT's 1-year correlation of daily returns is +0.27 with S&P 500 (SPY), +0.30 with Nasdaq 100 (QQQ), +0.49 with Bitcoin (BTC) and +0.12 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
4 of 6 analysts rate it a buy or strong buy, 2 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $18.00 is 183.0% above the price.More buy ratings than three months ago ›
4 of 6 rate it a buy now, against 4 of 6 three months ago.
QUBT Wall Street View
12-month price targets
The price, $6.36, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 26, 2026 | Ascendiant Capital | Maintains | Buy |
| Aug 11, 2026 | Cantor Fitzgerald | Maintains | Neutral |
| Aug 3, 2026 | Wedbush | Assumes | Neutral |
| Jun 29, 2026 | Rosenblatt | Maintains | Buy |
| Jun 24, 2026 | Rosenblatt | Maintains | Buy |
| Jun 15, 2026 | Ascendiant Capital | Maintains | Buy |
As of October 17, 2026, 6 Wall Street analysts cover QUBT: 4 rate it a buy or strong buy, 2 a hold and 0 a sell or strong sell. Their 12-month price targets range from $10.00 to $32.00, with a median of $18.00, 183.0% above the price of $6.36.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
QUBT trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
QUBT moves about 3.5% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much QUBT tends to move, against the market and on its own.
The long record
QUBT's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 3.50% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 99.9%, from February 2018 to July 2018, regained by December 2024.Most 1-year holds ended higher ›
44% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $318,000, against $42,055 in the S&P 500 (SPY).
QUBT Drawdowns & Recovery
As of October 17, 2026, QUBT's worst peak-to-trough fall over the last 10 years with dividends reinvested was -99.9% (February 2018 to July 2018); it regained that peak by December 2024, 77 months after the low, and 44% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into QUBT in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: QUBT beat the S&P 500 over this period: $318,000 against $42,055.
A $10,000 investment in QUBT in October 2016 would be worth about $318,000 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to QUBT, and which have not.
Strongest month, February: an average of +74.24%, up in 4 of 10 years.
Weakest month, April: an average of -24.22%, up in 1 of 10 years.
This month, October: has averaged -6.62%, up in 1 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, QUBT's strongest calendar month has been February (average +74.24%, up in 4 of 10 years) and its weakest April (average -24.22%, up in 1 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in QUBT, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in QUBT today could grow to about $30,452 by 2036 in the base case, with a 90th-percentile outcome near $231,029 and a 10th-percentile outcome around $4,014. Projections are statistical simulations, not guarantees.
QUBT Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $9.93 for QUBT by 2030 in the base case, from $6.36 today (1.6x over 4 years). The 10th-percentile path ends near $2.76. These are outcomes of a Monte Carlo simulation run on QUBT's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $3.75 | $7.11 | $13.49 | |
| 2028 | $3.21 | $7.95 | $19.67 | |
| 2029 | $2.93 | $8.88 | $26.95 | |
| 2030 | $2.76 | $9.93 | $35.77 | |
| 2031 | $2.65 | $11.10 | $46.51 |
Method: a lognormal simulation of QUBT's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. QUBT is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
QUBT insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought QUBT shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, QUBT insiders reported 11 open-market sales worth $32.1M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | Yuping Huang
Chief Executive Officer
|
Option | 584.9K | $4.8M |
| Aug 20, 2026 | Yuping Huang
Chief Executive Officer
|
Grant | 584.9K | $5.2M |
| Aug 20, 2026 | Yuping Huang
Chief Executive Officer
|
Grant | 584.9K | $4.8M |
| May 28, 2026 | Milan Begliarbekov
Chief Operating Officer
|
Grant | 24.8K | - |
| May 28, 2026 | Pouya Dianat
Officer
|
Grant | 24.8K | - |
| May 28, 2026 | Yuping Huang
Chief Executive Officer
|
Grant | 58.6K | - |
| Apr 13, 2026 | Robert B Fagenson
Director
|
Grant | 22.1K | $150.0K |
| Apr 13, 2026 | Eric Mark Schwartz
Director
|
Grant | 22.1K | $150.0K |
| Apr 13, 2026 | Javad Shabani
Director
|
Grant | 22.1K | $150.0K |
| Apr 13, 2026 | Michael C Turmelle
Director
|
Grant | 22.1K | $150.0K |
| Apr 13, 2026 | Carl Scott Weimer
Director
|
Grant | 22.1K | $150.0K |
| Mar 11, 2026 | Christopher Bruce Roberts
General Counsel
|
Sell | 78.3K | $614.5K |
| Mar 10, 2026 | Christopher Bruce Roberts
General Counsel
|
Option | 400.0K | $2.7M |
| Jan 7, 2026 | Milan Begliarbekov
Chief Operating Officer
|
Sell | 2.9K | $33.9K |
| Dec 31, 2025 | Milan Begliarbekov
Chief Operating Officer
|
Grant | 13.6K | $139.0K |
| Sep 15, 2025 | Robert B Fagenson
Director
|
Sell | 100.0K | $1.6M |
| Sep 12, 2025 | Yuping Huang
Chief Executive Officer
|
Grant | 400.0K | - |
| Sep 8, 2025 | Javad Shabani
Director
|
Sell | 37.5K | $572.7K |
| Sep 4, 2025 | Yuping Huang
Chief Executive Officer
|
Sell | 1.0M | $14.4M |
| Aug 25, 2025 | Pouya Dianat
Officer
|
Sell | 17.2K | $266.8K |
| Aug 18, 2025 | Pouya Dianat
Officer
|
Grant | 17.2K | - |
| Aug 18, 2025 | Javad Shabani
Director
|
Grant | 37.5K | - |
| Jun 30, 2025 | Yuping Huang
Chief Executive Officer
|
Option | 1.1M | $105 |
| Jun 13, 2025 | Christopher Boehmler
Chief Financial Officer
|
Option | 351.2K | $638.9K |
| Jun 12, 2025 | Christopher Boehmler
Chief Financial Officer
|
Sell | 46.4K | $928.8K |
| Jun 11, 2025 | Christopher Boehmler
Chief Financial Officer
|
Sell | 272.4K | $4.6M |
| Jun 9, 2025 | Michael C Turmelle
Director
|
Sell | 201.0K | $2.8M |
| Jun 3, 2025 | Michael C Turmelle
Director
|
Option | 201.0K | $478.7K |
| May 22, 2025 | Pouya Dianat
Officer
|
Option | 1.8K | $14.4K |
| May 19, 2025 | Yuping Huang
Officer, Director and Beneficial Owner
|
Sell | 500.0K | $5.9M |
| May 19, 2025 | Javad Shabani
Director
|
Sell | 40.0K | $465.9K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.